Simvastatin-corax may be available in the countries listed below.
Ingredient matches for Simvastatin-corax
Simvastatin is reported as an ingredient of Simvastatin-corax in the following countries:
- Germany
International Drug Name Search
Simvastatin-corax may be available in the countries listed below.
Simvastatin is reported as an ingredient of Simvastatin-corax in the following countries:
International Drug Name Search
Alzytec may be available in the countries listed below.
Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Alzytec in the following countries:
International Drug Name Search
Dotium may be available in the countries listed below.
Domperidone maleate (a derivative of Domperidone) is reported as an ingredient of Dotium in the following countries:
International Drug Name Search
Terbinafina Combix may be available in the countries listed below.
Terbinafine hydrochloride (a derivative of Terbinafine) is reported as an ingredient of Terbinafina Combix in the following countries:
International Drug Name Search
UK matches:
Rec.INN
D06BB03,J05AB01,S01AD03
0059277-89-3
C8-H11-N5-O3
225
Antiviral agent
6H-Purin-6-one, 2-amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-
Omalizumab may rarely cause a severe and sometimes life-threatening allergic reaction. This may occur right after receiving a dose or hours later. It may occur after the first dose or after many doses. Your doctor will monitor you for a period of time after your receive your dose of Omalizumab. Contact your doctor or seek medical care at once if you develop anxiety; chest tightness; cough; dizziness; fainting; fast or weak heartbeat; feeling unusually warm; flushing; hives; hoarseness; itching; rash; shortness of breath; swelling of the mouth, face, lips, tongue, or throat; trouble breathing; trouble swallowing; or wheezing.
Treating moderate to severe persistent asthma in certain patients who have had a positive allergy skin test and whose symptoms are not controlled by inhaled corticosteroids.
Omalizumab is an anti-immunoglobulin E (IgE) monoclonal antibody. It works by blocking your immune system's natural response to allergens, which can lead to an acute asthma attack. This action on the immune system (specifically, IgE) helps keep your air passages open and, over time, keeps asthma under better control.
Contact your doctor or health care provider right away if this applies to you.
Some medical conditions may interact with Omalizumab. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Omalizumab. However, no specific interactions with Omalizumab are known at this time.
Ask your health care provider if Omalizumab may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Omalizumab as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Omalizumab.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Bruising, itching, pain, redness, stinging, swelling, or warmth at the injection site; headache; itching and swelling of the skin; leg, arm, or ear pain; sinus inflammation.
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, tongue or throat); anxiety; calf pain, swelling, or tenderness; chest pain; confusion; cough; dizziness; fainting; fast, weak, or irregular heartbeat; feeling unusually warm; flushing; hoarseness; new or worsening breathing problems or shortness of breath; numbness or tingling; one-sided weakness; speech problems; swelling of a vein; symptoms of sinus or lung infection (congestion, cough, or fever); trouble swallowing; unusual bruising or bleeding; unusual lumps, growths, or moles; unusual swelling of the hands or feet; vision problems; wheezing.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: Omalizumab side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.
Omalizumab is usually handled and stored by a health care provider. If you are using Omalizumab at home, store Omalizumab as directed by your pharmacist or health care provider. Keep Omalizumab out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Omalizumab. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Agnicin may be available in the countries listed below.
Amikacin sulfate (a derivative of Amikacin) is reported as an ingredient of Agnicin in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
Alfaprostol is reported as an ingredient of Alfavet in the following countries:
International Drug Name Search
Bactelan may be available in the countries listed below.
Sulfamethoxazole is reported as an ingredient of Bactelan in the following countries:
Trimethoprim is reported as an ingredient of Bactelan in the following countries:
International Drug Name Search
Cépazine may be available in the countries listed below.
Cefuroxime axetil (a derivative of Cefuroxime) is reported as an ingredient of Cépazine in the following countries:
International Drug Name Search
Sotalol Basics may be available in the countries listed below.
Sotalol hydrochloride (a derivative of Sotalol) is reported as an ingredient of Sotalol Basics in the following countries:
International Drug Name Search